Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase in relatives from two families with a high prevalence of Graves' hyperthyroidism: a ten-year follow-up study
- PMID: 6284789
- DOI: 10.1007/BF00915973
Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase in relatives from two families with a high prevalence of Graves' hyperthyroidism: a ten-year follow-up study
Abstract
Thyroid-stimulating hormone (TSH) receptor antibodies and antibodies stimulating adenyl cyclase were measured in 47 relatives of patients with Graves' hyperthyroidism from two families with a high prevalence of the disease, in whom bioassays for the long-acting thyroid stimulator (LATS) had been performed 10 years earlier. Tests were also carried out in six propositi from the two families and age- and sex-matched normal subjects from six families. There had been no new cases of hyperthyroidism since the first study, although one subject was clinically and biochemically hyperthyroid at the time of study and two more were biochemically borderline hyperthyroid but clinically euthyroid. Levels of serum T4 thyrotropin, and percentage T3 resin uptake and free thyroxine indices were similar for relatives and normal subjects, although the mean serum T3 level for relatives was significantly greater than that for the normal subjects. Antibodies were not detected by either assay in any relative. Significant titers of antithyroglobulin antibodies were demonstrated in 4 of 44 relatives but in none of 46 normals tested, while thyroid cytoplasmic antibodies were detected in 8 of 44 relatives and 3 of 45 normals. The mean serum IgG for Graves' relatives was significantly greater than that for the normals, although the mean IgM and IgA levels for the two groups were not significantly different.
Similar articles
-
Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.Clin Endocrinol (Oxf). 1988 Oct;29(4):357-66. doi: 10.1111/j.1365-2265.1988.tb02884.x. Clin Endocrinol (Oxf). 1988. PMID: 2908031
-
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.N Engl J Med. 1991 Apr 4;324(14):947-53. doi: 10.1056/NEJM199104043241403. N Engl J Med. 1991. PMID: 1900575 Clinical Trial.
-
Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.J Clin Endocrinol Metab. 1976 Feb;42(2):341-54. doi: 10.1210/jcem-42-2-341. J Clin Endocrinol Metab. 1976. PMID: 946604
-
TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. doi: 10.1055/s-2004-817930. Exp Clin Endocrinol Diabetes. 2004. PMID: 15127319 Review.
-
Thyroid-stimulating autoantibodies.Vitam Horm. 1980;38:119-203. doi: 10.1016/s0083-6729(08)60485-9. Vitam Horm. 1980. PMID: 6291240 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous